New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls.
Read the Q3 2026 report
Thursday 19 November 2026
Export MODD’s income statement to Excel — free account
Modular Medical, Inc.
MODD- EPS
- n/m
- Free cash flow
- n/m
Quarter to September 2026, against a year earlier
1.91
0.09
+4.95%
Follow MODD
Alert me
Analysts’ price targets Wall Street, collected weekly
Analyst price targets
Free accountTen years at a glance
| Ten-year view | Analyst estimates Powerpack | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Group | Line | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | TTM Sep ’26 | Trend | 10 yrs | 2027e | 2028e | 2029e | Next 3/yr |
| Income, $m | ||||||||||||||||||
| Income, $m | Revenue | — | — | — | — | — | — | — | — | — | — | — | — | 35 | — | — | — | |
| Gross margin, % | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — | 0.00 | 0.0 pt | ||||||
| EBT | — | (1) | (3) | (5) | (7) | (19) | (14) | (17) | (19) | (28) | (27) | +60.0% | ||||||
| EBT margin, % | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.0 pt | ||||||
| Net income | — | (1) | (3) | (5) | (7) | (19) | (14) | (17) | (19) | (28) | (27) | +60.0% | ||||||
| Per share, $ | ||||||||||||||||||
| Per share, $ | Revenue | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | n/m | |||||
| Earnings | — | (1.48) | (4.60) | (9.01) | (35.67) | (82.28) | (34.40) | (23.42) | (15.31) | (12.36) | (6.49) | +30.3% | ||||||
| Cash flow | — | (1.78) | (3.27) | (6.88) | (28.57) | (45.26) | (27.32) | (18.72) | (12.75) | (10.40) | (3.18) | +24.7% | ||||||
| Capex | — | (0.03) | (0.14) | (0.44) | (0.53) | (0.24) | (4.06) | (2.28) | (2.02) | (1.72) | (0.38) | +63.0% | ||||||
| Free cash flow | — | (1.82) | (3.41) | (7.32) | (29.10) | (45.50) | (31.39) | (21.00) | (14.77) | (12.12) | (3.56) | +26.8% | ||||||
| Book value | — | 9.73 | 11.72 | 4.84 | (6.17) | 38.98 | 12.60 | 15.48 | 13.85 | 5.67 | 1.44 | (6.5%) | ||||||
| Shares, m | — | 0 | 1 | 1 | 0 | 0 | 0 | 1 | 1 | 2 | 4 | +22.7% | ||||||
| Valuation, × | ||||||||||||||||||
| Valuation, × | P/E | — | — | — | — | — | — | — | — | — | — | 0 | — | |||||
| P/S | — | — | — | — | — | — | — | — | — | — | 0 | — | ||||||
| P/B | — | — | — | — | — | — | — | — | — | — | 0 | — | ||||||
| EV/Sales | — | — | — | — | — | — | — | — | — | — | 0 | — | ||||||
| EV/FCF | — | — | — | — | — | — | — | — | — | — | 0 | — | ||||||
| Cash, $m | ||||||||||||||||||
| Cash, $m | Operating cash flow | — | (1) | (2) | (4) | (6) | (10) | (11) | (14) | (16) | (24) | (25) | +53.0% | |||||
| Capex | — | 0 | 0 | 0 | 0 | 0 | (2) | (2) | (2) | (4) | (3) | +100.1% | ||||||
| Free cash flow | — | (1) | (2) | (4) | (6) | (10) | (13) | (16) | (18) | (28) | (28) | +55.6% | ||||||
| Balance, $m | ||||||||||||||||||
| Balance, $m | Working capital | — | 4 | 6 | 3 | (2) | 8 | 3 | 8 | 12 | 6 | 5 | +3.5% | |||||
| Net debt | — | (4) | (7) | (3) | (1) | (9) | (4) | (9) | (13) | (7) | (5) | +6.2% | ||||||
| Shareholders’ equity | — | 4 | 6 | 3 | (1) | 9 | 5 | 12 | 17 | 13 | 11 | +14.7% | ||||||
| Returns, % | ||||||||||||||||||
| Returns, % | ROA | — | (12.00) | (46.23) | (101.24) | (241.63) | (308.12) | (162.41) | (165.97) | (115.69) | (168.27) | (212.69) | (156.3) pt | |||||
| ROIC | — | (1,867.15) | 0.00 | 0.00 | 0.00 | 0.00 | (679.23) | (475.71) | (298.97) | (286.27) | (263.11) | +1,580.9 pt | ||||||
| ROE | — | (31.96) | (47.06) | (113.79) | (920.35) | (492.82) | (199.51) | (210.34) | (131.58) | (188.05) | (270.84) | (156.1) pt | ||||||
| People | ||||||||||||||||||
| People | Employees | — | — | 6 | 13 | 20 | 25 | 38 | 40 | 54 | 51 | — | +35.8% | |||||
| Revenue/emp, $m | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | n/m | ||||||
Negative figures in brackets.
estimates
Fundamentals updated 18 Nov 2026
Modular Medical, Inc. vs peers in Medical Devices (Q) = latest quarter vs a year earlier
| Company | Market cap | P/E | Fwd P/E | Revenue growth (Q) | EPS growth (Q) | FCF growth (Q) | Gross margin (Q) | EBIT margin (Q) | Compare |
|---|---|---|---|---|---|---|---|---|---|
| NNOX Nano-X Imaging Ltd. | $20.6M | — (loss-making) | — (loss-making) | +36.71% (above 0%: growing) | n/m | −21.37% (below 0%: shrinking) | (1,050.87%) | (1,334.91%) | Compare |
| MODD Modular Medical, Inc. | $17.7M | — (loss-making) | — | — | n/m | −2.99% (below 0%: shrinking) | 0.00% | 0.00% | |
| CTSO Cytosorbents Corporation | $17.5M | — (loss-making) | — (loss-making) | +0.17% (above 0%: growing) | n/m | +64.90% (above 0%: growing) | 73.18% | (27.39%) | Compare |
| CVRX CVRx, Inc. | $17.2M | — (loss-making) | — (loss-making) | −5.84% (below 0%: shrinking) | n/m | −9.91% (below 0%: shrinking) | 86.74% | (94.31%) | Compare |
| PMI Flag Ship Acquisition Corp | $17.1M | — (loss-making) | — (loss-making) | −81.72% (below 0%: shrinking) | n/m | +69.36% (above 0%: growing) | 43.78% | (968.20%) | Compare |
| ALUR Allurion Technologies, Inc. | $16.7M | — (loss-making) | — (loss-making) | −47.19% (below 0%: shrinking) | n/m | +65.98% (above 0%: growing) | 41.70% | (126.60%) | Compare |
| SNWV Sanuwave Health Inc. | $14.7M | 3.3× | — (loss-making) | −23.88% (below 0%: shrinking) | n/m | −119.02% (below 0%: shrinking) | 77.27% | (12.50%) | Compare |
| RBOT Vicarious Surgical Inc. | $14.3M | — (loss-making) | — | — | n/m | +47.33% (above 0%: growing) | 0.00% | 0.00% | Compare |
| PETV PetVivo Holdings, Inc. | $12.9M | — (loss-making) | — (loss-making) | −29.84% (below 0%: shrinking) | n/m | +56.35% (above 0%: growing) | 92.15% | (907.42%) | Compare |
| Median of peers | $16.9M | — | — | −23.88% | — | +51.84% | 58.48% | (110.46%) |
Pay and ownership Proxy statement filed 1 October 2026
Chief executive’s pay
| Year | Total pay | Actually paid | $100 invested |
|---|---|---|---|
| 2026 | 47.00k | 17.06k | (90.49) |
Ownership
Directors and executive officers, together
2.25%
AWM Investment Company
9.99%
Total pay is as the Summary Compensation Table states it; actually paid revalues the year’s share awards
at its end, as the SEC’s pay-versus-performance rule asks. $100 invested is what $100 in the company’s
shares at the start of the earliest year shown was worth at each year’s end.
Ownership is the proxy’s own table: the directors and officers as a group, and every holder of 5% or more.
Read the proxy statement
Modular Medical, Inc. (MODD) Latest News
What happened
- Modular Medical Launches Digital Learning Tools to Support Adoption of Pivot Insulin Delivery System ACCESS Newswire
- Modular Medical Secures National PBM Contract For Pivot Insulin Pump
- Modular Medical Announces Contract with National U.S. Pharmacy Benefit Manager, Expanding Access to Pivot Tubeless Patch Pump
- Modular Medical Announces FDA Clearance of Pivot Tubeless Insulin Patch Pump Enhancements
- EXCLUSIVE: Modular Medical Secures FDA Clearance for Pivot Software Upgrades
- Modular Medical Announces Launch of Pivot Insulin Delivery System Across Five Key U.S. Markets Beginning October 2026
- EXCLUSIVE: Modular Medical Advances Commercial Rollout With First Active Users Of Pivot Insulin Pump
- Modular Medical Announces FDA Submission of Pivot Tubeless Insulin Patch Pump Enhancements
- Modular Medical Delivers Insulin to First Patients on Pivot Tubeless Insulin Patch Pump
- EXCLUSIVE: Modular Medical Advances Commercial Rollout With First Active Users Of Pivot Insulin Pump
19 more headlines
- Modular Medical Announces Positive Notified Body Decision on ISO 13485:2016 Certification ACCESS Newswire
- Modular Medical Announces Formation of Pivot Innovation Council and Appointment of Robert Gabbay, MD, PhD, FACP as Chairman
- Modular Medical and IMO Health Launch Strategic Pilot to Enable Real Time Insulin Pump Patient Identification Into Electronic Health Records
- Modular Medical Receives Research Demonstrating Positive Payor Reception of Pivot Tubeless Patch Pump
- Modular Medical Announces Shipment of Pivot Tubeless Patch Pumps
- Modular Medical Announces Commercial Availability of Pivot Tubeless Insulin Patch Pump Ahead of Commercial Expansion ACCESS Newswire
- EXCLUSIVE: Modular Medical Transitions To Commercial Stage With Pivot Insulin Pump Launch Benzinga
- Modular Medical Announces Pricing of $3.4 Million Registered Direct Offering of Common Stock
- Modular Medical Regains Compliance with Nasdaq Minimum Bid Price Requirement ACCESS Newswire
- Modular Medical Receives FDA 510(k) Clearance for Pivot Tubeless Insulin Patch Pump ACCESS Newswire
- Modular Medical Announces $12.0 Million Public Offering Priced at a Premium to Market ACCESS Newswire
- Modular Medical starts production of validation lots for Pivot pump set TipRanks
- Modular Medical Achieves Key Manufacturing Milestone for Pivot Tubeless Insulin Patch Pump ACCESS Newswire
- Modular Medical Receives 180-Day Extension to Regain Compliance with Nasdaq Minimum Bid Price Rule ACCESS Newswire
- This Modular Medical Insider Increased Their Holding By 59% Last Year Simply Wall St.
- Modular Medical Announces Pricing of $4.68 Million Public Offering ACCESS Newswire
- Modular Medical Announces Proposed Public Offering ACCESS NewswireBarchartZacksMT NewswiresMedical Device NetworkSimply Wall St.ZacksMedTech Dive
- Modular Medical Receives IRB Approval to Deliver Insulin Using Pivot Patch Pump ACCESS NewswireMedical Device NetworkInsider MonkeyInvesting.comBarchartStockStoryMT NewswiresMedTech Dive
- Modular Medical Submits Pivot Tubeless Insulin Patch Pump for FDA 510(k) Clearance ACCESS Newswire